Hacettepe University

hacettepe.edu.tr

Total trials

957

Active

184

Phase 3

1

Total enrollment

75,540

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 5 of 5 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Bupivacaine2
Morphine2
Paracetamol2
Diklofenak Sodyum1
propofol1

Next readouts

  • 2025-12-01
  • 2025-12-01

Top conditions

  • Neck Pain28
  • Cerebral Palsy22
  • Quality of Life18
  • Duchenne Muscular Dystrophy18
  • Low Back Pain17
  • Multiple Sclerosis17
  • Stroke17
  • Healthy16

Frequently asked questions about Hacettepe University

How many clinical trials does Hacettepe University have on ClinicalTrials.gov?
Hacettepe University is listed as the lead sponsor on 957 clinical trials in ClinicalTrials.gov, 184 of which are currently active (recruiting, enrolling, or ongoing).
How many of Hacettepe University's trials are in Phase 3?
1 of Hacettepe University's trials are in Phase 3, spread across 5 active drug programs.
What therapeutic areas does Hacettepe University focus on?
Hacettepe University's most-studied conditions on ClinicalTrials.gov are Neck Pain, Cerebral Palsy, Quality of Life, Duchenne Muscular Dystrophy, Low Back Pain.
When are Hacettepe University's next clinical trial readouts?
Hacettepe University has 2 upcoming primary-completion readouts tracked here; the soonest is “Comparison Paravertebral and Serratus Anterior Plane Block in Video-assisted Thoracoscopic Surgery.”, expected around 2025-12-01.